Mild ast elevation as an early sign of COVID-19 severity in a multicenter Madrid cohort

• Published in: Revista española de enfermedades digestivas Vol. 113; no. 11; pp. 780 - 786
• Main Authors: Fernández Carrillo, Carlos, Perelló, Christie, Llop Herrera, Elba, García-Samaniego, Javier, Romero, Miriam, Mostaza, José María, Ibáñez, Luis, Bañares Cañizares, Rafael, Bighelli, Federico, Usón Perón, Clara, Fernández Vázquez, Inmaculada, Hernández Castro, Olga, Albillos, Agustín, Lalueza, Antonio, Malo de Molina, Rosa, Muñez, Elena, Jiménez Tejero, Elena, Calleja Panero, José Luis
• Format: Journal Article
• Language: English; Spanish
• Published: Spain Sociedad Espanola de Patologia Digestivas 01.11.2021
• ISSN: 1130-0108
• DOI: 10.17235/reed.2021.8007/2021

Liver enzyme elevation has been reported for SARS-CoV-2 disease (COVID-19) in heterogeneous cohorts, mainly from China. Comprehensive reports from other countries are needed. We dissect the pattern, evolution and predictive value of such abnormalities in a cohort from Madrid, Spain. Retrospective study with prospective 14-day follow-up of 373 patients with confirmed COVID-19 in five Madrid hospitals, including 50 outpatients. COVID-19 severe course was defined as need of mechanical ventilation. A total of 33.1% hospitalised patients showed baseline AST elevation and 28.5% showed ALT elevation, contrasting with 12% and 8% of outpatients (P≤0.001). Baseline AST, ALT and GGT levels correlated with LDH and C-reactive protein levels (CRP) (r≤0.598, P<0.005). AST elevation was associated with other severity markers such as male sex, lymphopenia and pneumonia on X-ray (P<0.05 all). ALP and Bilirubin levels were rarely increased. Patients with elevated baseline AST displayed progressive normalization of this enzyme and increase in ALT and GGT levels. Patients with normal baseline AST showed a flattened evolution pattern with levels in range. Patients with a severe course of COVID-19 showed more frequently elevated baseline AST than those with a milder evolution (54.2% vs. 25.4%, P<0.001). Age, AST and CRP were independent risk factors for a severe course of COVID-19. Mild liver enzyme elevation is associated with COVID-19 severity. Baseline AST is an independent predictor of severe COVID-19 course, while it tends to normalize over time. ALT and GGT show late elevation.